145 related articles for article (PubMed ID: 37104903)
21. Preparation of osthole-polymer solid dispersions by hot-melt extrusion for dissolution and bioavailability enhancement.
Yun F; Kang A; Shan J; Zhao X; Bi X; Li J; Di L
Int J Pharm; 2014 Apr; 465(1-2):436-43. PubMed ID: 24576810
[TBL] [Abstract][Full Text] [Related]
22. Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability.
Zhaojie M; Ming Z; Shengnan W; Xiaojia B; Hatch GM; Jingkai G; Li C
Int J Pharm; 2014 Jun; 467(1-2):50-9. PubMed ID: 24607213
[TBL] [Abstract][Full Text] [Related]
23. Design and Characterization of HY-038 Solid Dispersions via Spray Drying Technology: In Vitro and In Vivo Evaluations.
Jiang T; Han L; Lu E; He W; Du S; Sha X
AAPS PharmSciTech; 2021 Nov; 22(8):267. PubMed ID: 34750638
[TBL] [Abstract][Full Text] [Related]
24. Development of amorphous solid dispersion formulations of a poorly water-soluble drug, MK-0364.
Sotthivirat S; McKelvey C; Moser J; Rege B; Xu W; Zhang D
Int J Pharm; 2013 Aug; 452(1-2):73-81. PubMed ID: 23651642
[TBL] [Abstract][Full Text] [Related]
25. Development of a rebamipide solid dispersion system with improved dissolution and oral bioavailability.
Pradhan R; Tran TH; Choi JY; Choi IS; Choi HG; Yong CS; Kim JO
Arch Pharm Res; 2015 Apr; 38(4):522-33. PubMed ID: 24895145
[TBL] [Abstract][Full Text] [Related]
26. Tadalafil solid dispersion formulations based on PVP/VA S-630: Improving oral bioavailability in rats.
Choi JS; Lee SE; Jang WS; Byeon JC; Park JS
Eur J Pharm Sci; 2017 Aug; 106():152-158. PubMed ID: 28579005
[TBL] [Abstract][Full Text] [Related]
27. Characterization and pharmacokinetic study of itraconazole solid dispersions prepared by solvent-controlled precipitation and spray-dry methods.
Sim T; Lim C; Lee JW; Kim DW; Kim Y; Kim M; Choi S; Choi HG; Lee ES; Kim KS; Kang W; Oh KT
J Pharm Pharmacol; 2017 Dec; 69(12):1707-1715. PubMed ID: 28872678
[TBL] [Abstract][Full Text] [Related]
28. Solid Dispersion of Kaempferol: Formulation Development, Characterization, and Oral Bioavailability Assessment.
Colombo M; de Lima Melchiades G; Michels LR; Figueiró F; Bassani VL; Teixeira HF; Koester LS
AAPS PharmSciTech; 2019 Feb; 20(3):106. PubMed ID: 30746582
[TBL] [Abstract][Full Text] [Related]
29. Physical properties and solubility studies of Nifedipine-PEG 1450/HPMCAS-HF solid dispersions.
Haware RV; Vinjamuri BP; Gavireddi M; Dave VS; Gupta D; Chougule MB; Stagner WC
Pharm Dev Technol; 2019 Jun; 24(5):550-559. PubMed ID: 30175691
[TBL] [Abstract][Full Text] [Related]
30. Oral Bioavailability Enhancement and Anti-Fatigue Assessment of the Andrographolide Loaded Solid Dispersion.
Yen CC; Liang YK; Cheng CP; Hsu MC; Wu YT
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260319
[TBL] [Abstract][Full Text] [Related]
31. A Combined Utilization of Plasdone-S630 and HPMCAS-HF in Ziprasidone Hydrochloride Solid Dispersion by Hot-Melt Extrusion to Enhance the Oral Bioavailability and No Food Effect.
Xue X; Chen G; Xu X; Wang J; Wang J; Ren L
AAPS PharmSciTech; 2019 Jan; 20(1):37. PubMed ID: 30604142
[TBL] [Abstract][Full Text] [Related]
32. A pre-formulation study of a polymeric solid dispersion of paclitaxel prepared using a quasi-emulsion solvent diffusion method to improve the oral bioavailability in rats.
Piao H; Yang L; Piao H; Wang P; Shi H; Fang L; Cui F
Drug Dev Ind Pharm; 2016; 42(3):353-63. PubMed ID: 26161937
[TBL] [Abstract][Full Text] [Related]
33. Supersaturated controlled release matrix using amorphous dispersions of glipizide.
Lu Z; Yang Y; Covington RA; Bi YV; Dürig T; Ilies MA; Fassihi R
Int J Pharm; 2016 Sep; 511(2):957-68. PubMed ID: 27492020
[TBL] [Abstract][Full Text] [Related]
34. A silica-supported solid dispersion of bifendate using supercritical carbon dioxide method with enhanced dissolution rate and oral bioavailability.
Cai C; Liu M; Li Y; Guo B; Chang H; Zhang X; Yang X; Zhang T
Drug Dev Ind Pharm; 2016; 42(3):412-7. PubMed ID: 26219343
[TBL] [Abstract][Full Text] [Related]
35. Enhanced dissolution rate and oral bioavailability of Ginkgo biloba extract by preparing solid dispersion via hot-melt extrusion.
Wang W; Kang Q; Liu N; Zhang Q; Zhang Y; Li H; Zhao B; Chen Y; Lan Y; Ma Q; Wu Q
Fitoterapia; 2015 Apr; 102():189-97. PubMed ID: 25446043
[TBL] [Abstract][Full Text] [Related]
36. Stability-enhanced hot-melt extruded amorphous solid dispersions via combinations of Soluplus® and HPMCAS-HF.
Alshahrani SM; Lu W; Park JB; Morott JT; Alsulays BB; Majumdar S; Langley N; Kolter K; Gryczke A; Repka MA
AAPS PharmSciTech; 2015 Aug; 16(4):824-34. PubMed ID: 25567525
[TBL] [Abstract][Full Text] [Related]
37. Stability and solubility enhancement of ellagic acid in cellulose ester solid dispersions.
Li B; Harich K; Wegiel L; Taylor LS; Edgar KJ
Carbohydr Polym; 2013 Feb; 92(2):1443-50. PubMed ID: 23399175
[TBL] [Abstract][Full Text] [Related]
38. Enteric and hydrophilic polymers enhance dissolution and absorption of poorly soluble acidic drugs based on micro-environmental pH-modifying solid dispersion.
Zhang S; Xu X; Sun W; Zhang Z; Pan B; Hu Q
Eur J Pharm Sci; 2022 Jan; 168():106074. PubMed ID: 34798261
[TBL] [Abstract][Full Text] [Related]
39. Enhanced bioavailability of sirolimus via preparation of solid dispersion nanoparticles using a supercritical antisolvent process.
Kim MS; Kim JS; Park HJ; Cho WK; Cha KH; Hwang SJ
Int J Nanomedicine; 2011; 6():2997-3009. PubMed ID: 22162657
[TBL] [Abstract][Full Text] [Related]
40. Formulation of aripiprazole-loaded pH-modulated solid dispersions via hot-melt extrusion technology: In vitro and in vivo studies.
McFall H; Sarabu S; Shankar V; Bandari S; Murthy SN; Kolter K; Langley N; Kim DW; Repka MA
Int J Pharm; 2019 Jan; 554():302-311. PubMed ID: 30395959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
